Christina Sveen

  • Research Assistant; MSc
  • +47 22 78 17 62


Christina Sveen finished her Bachelor Degree in 2020 as a Bioengineer before commencing her Master Degree in Bio Medicine at Oslo Metropolitan University (2020-2022). She performed her Master’s thesis under the supervision of Dr. Nikolai Engedal and Dr. Natalie Jayne Kurganovs, where she investigated the role of autophagy and autophagy-related genes in the development of melanoma. After graduating her Masters in June 2022, Sveen continued working as a Special Engineer in the “Autophagy in cancer” project group where she has contributed to numerous projects, including involvement in international collaborations.


  1. Nyakas M, Fleten KG, Haugen MH, Engedal N, Sveen C, Farstad IN, Flørenes VA, Prasmickaite L, Mælandsmo GM, Seip K (2022)
    AXL inhibition improves BRAF-targeted treatment in melanoma
    Sci Rep, 12 (1), 5076
    DOI 1038/s41598-022-09078-z, PubMed 35332208
  2. Tamargo-Gómez I, Martínez-García GG, Suárez MF, Mayoral P, Bretones G, Astudillo A, Prieto-Lloret J, Sveen C, Fueyo A, Engedal N, López-Otín C, Mariño G (2023)
    Analysis of ATG4C function in vivo
    Autophagy, 1-22 (in press)
    DOI 1080/15548627.2023.2234799, PubMed 37459465
Page visits: 1564